Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glutamate-rich protein 6 (ERICH6) is a nuclear protein encoded by the ERICH6 gene, located on chromosome 3. It is expressed selectively in spermatogonia in the testis and is associated by annotation with certain neurological disorders, such as Giant Axonal Neuropathy 2 and Pyruvate Dehydrogenase E1-Alpha Deficiency[3][7]. The biological function of ERICH6 remains largely uncharacterized, though recent evidence suggests its antisense transcript (ERICH6.AS1) may play a role in modulating immune responses and serve as a prognostic biomarker in cancers such as cervical squamous cell carcinoma[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutamate-rich protein 6 (ERICH6).